HhAntag
CAS No. 496794-70-8
HhAntag( HhAntag | Hh-Antag | Hh Antag )
Catalog No. M17525 CAS No. 496794-70-8
HhAntag is a small molecule inhibitor of GLI1-mediated transcription, an essential down-stream element of the Hedgehog (Hh) pathway with the anti-tumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 102 | In Stock |
|
5MG | 185 | In Stock |
|
10MG | 320 | In Stock |
|
25MG | 529 | In Stock |
|
50MG | 771 | In Stock |
|
100MG | 1062 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHhAntag
-
NoteResearch use only, not for human use.
-
Brief DescriptionHhAntag is a small molecule inhibitor of GLI1-mediated transcription, an essential down-stream element of the Hedgehog (Hh) pathway with the anti-tumor activity.
-
DescriptionHhAntag is a GLI1-mediated transcription inhibitor. It acts as an inhibitor of the Shh pathway.
-
In VitroHhAntag (2-30 μM; 72?hours) demonstrates to be?10-times more potent than the natural product SMO antagonist, cyclopamine, at inhibiting Hh pathway activity and it inhibits Hh signalling pathway sensitivitive cells with IC50 values ranging from 2?μM to >30?μM.HhAntag inhibits AsPC-1, BXPC-3, CFPAC, HPAC, HPAF-II, KP4, Panc 03.27, PA-TU-8902, PSN-1, SU.86.86 cells with IC50 values of 30 μM, 5.4 μM, 5.8 μM, 2.7 μM, 6.2 μM,10.3 μM, 2.5 μM, 2.9 μM, 5.8 μM and 2.7 μM, respectively.HhAntag (100 nM) is needed to completely inhibit Hh signalling in a Hh-responsive human mesenchymal cell line (HEPM) expressing a?GLI?luciferase reporter construct (HEPM-rep), the IC50?of 5?nM 400-times lower than that required to inhibit cell growth by 50% in the most sensitive cancer cell line (1.9?μM).
-
In VivoHhAntag (oral administraion; 75 mg/kg or 100 mg/kg; twice daily; 25 days) results in significant growth delay in HT55 and HT-29 colorectal cell line xenografts models, with average tumour growth inhibitions of 29% and 48%, respectively. Whereas HhAntag had no effect on the growth of DLD-1 xenografts. Animal Model:Primary human xenografts?in?female CD1 nu/nu mice of 6–8?weeks (DLD-1, HT55 and HT-29 cells)Dosage:75 mg/kg or 100 mg/kg Administration:Oral administraion; twice daily; 25 days Result:Resulted in growth delay of HT55 and HT-29 xenografts, but had no effects on DLD-1 xenografts.
-
SynonymsHhAntag | Hh-Antag | Hh Antag
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorGli
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number496794-70-8
-
Formula Weight450.92
-
Molecular FormulaC24H23ClN4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL. 221.77 mM; H2O : < 0.1 mg/mL
-
SMILESC(=O)(c1cc(cc(c1)OC)OC)Nc1cc(c(cc1)Cl)c1nc2c([nH]1)cc(cc2)N(C)C
-
Chemical NameN-[4-Chloro-3-[6-(dimethylamino)-1H-benzimidazol-2-yl]phenyl]-3,5-dimethoxybenzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Actis, Marcelo; Connelly, Michele C.; Mayasundari, Anand et al. Biopolymers (2011), 95(1), 24-30.
molnova catalog
related products
-
GSK2193874
GSK2193874 was identified as a selective orally active TRPV4 blocker.
-
Pellitorine
Pellitorine is an extract of Tetradium daniellii, and acts as a TRPV1 antagonist.
-
MK-2295
MK-2295 is a potent TRPV1 antagonist. MK-2295 can be used in studies about the treatment of chronic pain.